PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “HYDROXOCOBALAMIN”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 631 records · Page 35Linked to original sources
PubMed1983

Effect of vitamin B12 status on performance of the lactating ewe and gluconeogenesis from propionate.

Ewes fed a diet containing .06 ppm cobalt prior to and after parturition were used to examine effects of hydroxycobalamin supplementation upon production of milk. Four ewes were assigned to each of three treatments after hand milking at 3 wk postpartum. At 7 wk postpartum, B12 concentrations in liver were enhanced in the group receiving intramuscular injections of 200 micrograms on alternate days (750 ng/g wet liver) relative to low groups that received 20 and 0 micrograms on alternate days (190 and 200 ng/g wet liver). Following 1 wk of treatment, B12-enhanced ewes had greater daily intake of feed and increased live weight. Vitamin B12 status was without significant effect on production of milk, total solids, fat, and solids-not-fat at 4, 5, and 6-wk milkings; however, production of milk protein was increased for B12-enhanced ewes. After lactations were terminated and feed intakes standardized, slices of liver obtained from B12-enhanced ewes incorporated 2-carbon 14-labeled propionate into glucose at rates greater than did slices from low B12 ewes. Subclinical changes affecting production may occur in lactating sheep when B12 status is at the lower end of what usually is considered the normal range.

Animals↗
PubMed2001

[DNA degradation and repair in human laryngeal carcinoma HEp-2 cells after combined exposure to vitamin B12b and ascorbic acid].

The formation and accumulation of DNA fragments containing no more than 23,000 pairs of bases were observed under exposure of human larynx epidermoid carcinoma cells (Hep-2) to "chemical nuclease", oxycobalamin (vitamin B12b) and ascorbic acid (vitamin C). The obtained DNA damages were repaired more slowly than those induced by gamma-irradiation in the dose adequate to the level of DNA damages. DNA reparation was not revealed after washing the cells from vitamin B12b and ascorbic acid, and in the course of cell incubation with ascorbic acid. Vitamin B12b and ascorbic acid separately did not induce degradation of DNA. DNA damages induced by "chemical nuclease" action precede the cell death observed later.

Ascorbic Acid↗
PubMed2002

Missed diagnosis of vitamin B12 deficiency presenting with paraesthetic symptoms.

Paraesthesia is a common presenting complaint in vitamin B12 deficiency. Since this condition is partially reversible with repletion, this is a diagnosis not to be missed. Two cases in which the diagnosis was initially overlooked are presented, emphasising that the paraesthesia associated with vitamin B12 deficiency may be central (myelopathic) or peripheral (neuropathic) in origin.

Electromyography↗
PubMed2002

Effect of homocysteine reduction by B-vitamin supplementation on markers of clotting activation.

Homocysteine may have an effect on risk of cardiovascular disease by stimulating procoagulant factors and/or impair anti-coagulant mechanisms or fibrinolysis. However, data in humans of such effects are sparse. In this intervention study, we examined the effect of homocysteine lowering by B-vitamin supplementation on prothrombin fragments 1 and 2 (F1 + 2), thrombin-antithrombin complex (TAT), and fibrin degradation products (D-dimer). The study comprised 118 healthy volunteers, 50 with homocysteine > 16 mumol/L and 68 with homocysteine < or = 16 mumol/L, who were randomized to placebo or high-dose B-vitamin supplements (5 mg folic acid, 0.4 mg hydroxycobalamin, and 50 mg pyridoxine) daily for 8 weeks. Although homocysteine concentrations were 27.7% (p < 0.0001) reduced in the B-vitamin group compared to the placebo group, no effect on F1 + 2 and TAT concentrations was observed. A 10.4% reduction was observed for D-dimer (p = 0.08). In conclusion, it appears that in healthy subjects homocysteine reduction by B-vitamin supplementation has a modest beneficial effect on clotting activation.

Adult↗
PubMed2002

Intravenous nutrient therapy: the "Myers' cocktail".

Building on the work of the late John Myers, MD, the author has used an intravenous vitamin-and-mineral formula for the treatment of a wide range of clinical conditions. The modified "Myers' cocktail," which consists of magnesium, calcium, B vitamins, and vitamin C, has been found to be effective against acute asthma attacks, migraines, fatigue (including chronic fatigue syndrome), fibromyalgia, acute muscle spasm, upper respiratory tract infections, chronic sinusitis, seasonal allergic rhinitis, cardiovascular disease, and other disorders. This paper presents a rationale for the therapeutic use of intravenous nutrients, reviews the relevant published clinical research, describes the author's clinical experiences, and discusses potential side effects and precautions.

Administration, Oral↗